Diabetes Device
FDA clears novel smart cap for insulin pens
The FDA granted 510(k) clearance for a first-of-its-kind connected smart cap for insulin pens, recommending insulin doses for people with diabetes prescribed multiple daily injection therapy, according to an industry press release.
Fewer hospitalizations, but higher total health costs 1 year after CGM initiation
People with type 1 diabetes in Israel had fewer hospitalizations with high adherence to continuous glucose monitoring 1 year after starting to use the device, but also experienced higher total health costs, according to study data.
Baseline time in range predicts artificial pancreas success for children with diabetes
A higher baseline time in range is the strongest predictor of glucose response with a closed-loop insulin delivery system for children with type 1 diabetes, according to data published in Diabetes Technology & Therapeutics.
Artificial pancreas may be safe for young children with type 1 diabetes
A modified version of an FDA-approved close-loop insulin delivery system may be effective for children aged 2 to 5 years with type 1 diabetes, according to study data published in Diabetes Technology & Therapeutics.
Most adults with diabetes open to remote digital monitoring
Nearly two-thirds of adults with diabetes said they would be willing to adopt remote digital monitoring if the method was just as or more effective than their current monitoring, according to study data.
COVID-19 pandemic shows CGM ‘supportive tool’ for broad inpatient use
The risk for severe COVID-19 complications is significantly higher for people with diabetes, and data suggest glucose management may play a vital role in disease outcomes.
Diabetes technology, social determinants of health updates top ADA 2021 Standards of Care
The American Diabetes Association published its 2021 Standards of Care, with new evidence-based updates ranging from diabetes technology and self-management education to socioeconomic disparities and COVID-19 vaccine recommendations.
CGM use ‘reliable, accurate’ for ICU in COVID-19
The use of continuous glucose monitoring technology in critically ill patients with COVID-19 and diabetes is reliable and accurate for real-time glucose trending, according to data from a pilot study.
Proposed CMS change could expand access to diabetes devices
CMS announced proposed new changes that could expand Medicare coverage for continuous glucose monitors and insulin pumps, according to an agency press release.
Smart insulin pens address challenges of multiple daily injection therapy
In this issue, Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with nurse practitioner and diabetes care and education specialist Colleen Miller-Owen, MSN, APRN, CDCES, about the benefits of smart insulin pens for multiple daily injections.